SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA token continues to face intense skepticism from the community, with many investors labeling it a pump-and-dump scheme following its severe decline from peak valuations. Market participants are actively debating the token's lack of utility and transparency, frequently contrasting its performance with mainstream cryptocurrencies while expressing frustration over the losses linked to the broader Trump-affiliated crypto ecosystem.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is trending following the publication of positive Phase 3 VIKTORIA-1 trial data, which demonstrated significant survival benefits for its investigational breast cancer drug, gedatolisib. Investors are actively discussing the potential for an accelerated FDA approval timeline, the strategic implications of a recent capital raise, and the stock's long-term value as a potential first-in-class standard of care.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI Holdings is capturing investor interest following a strategic partnership with World Wide Technology and aggressive long-term capacity expansion plans. The community is heavily focused on the stock's potential for a significant short squeeze driven by a thin float, sparking intense debate regarding its volatility and future trajectory.

Barclays Bank Plc engages in providing commercial banking services. It offers personal, premier, business, and corporate banking products and services to its customers. Its services include current accounts, savings, investments, mortgages, loans, insurance, credit cards, and online banking. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom.

Barclays Bank PLC - iPathÂ® Series B S&P 500Â® VIX Short-Term FuturesTM ETN

iPath S&P 500 VIX Short-Term Futures ETN

Investors are closely watching the iPath S&P 500 VIX Short-Term Futures ETN (VXX) as market participants debate whether extreme volatility-shorting behavior signals a major market peak or continued complacency. Community discussion is currently fixated on whether the recent compression in volatility indices, coupled with macroeconomic uncertainty, is setting the stage for a significant capitulatory event or another aggressive melt-up.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

The RAGE crypto community is rallying behind the project with intense conviction, emphasizing long-term 'bagworking' and the creation of OG-style rage comics to drive mindshare. Investors are actively pushing to secure a top market position while warning against copycat tickers and urging others to join their grassroots effort before a potential breakout.

Bob’s Discount Furniture, Inc. is a holding company, which engages in the retail of home furnishings. The firm's products include reclining sofa, table lamp, storage ottoman, top coffee and end table set, rug, storage television stand, and swivel chair. Its store locations include New England, New York, Mid Atlantic, Midwest, and West. The company was founded by Robert Kaufman in 1991 and is headquartered in Manchester, CT.

Bob`s Discount Furniture Inc.

Bob's Discount Furniture is generating intense debate following its recent market debut, with investors weighing concerns over selling pressure and IPO timing against the company's brand recognition as a value-focused retailer. The community remains divided, with technical analysts tracking consolidation patterns while others express skepticism regarding long-term business quality and exposure to tariff risks.

Ecopetrol SA engages in the exploration, development, and production of crude oil and natural gas. It operates through the following segments: Exploration and Production, Transportation and Logistics, and Refining and Petrochemicals. The Exploration and Production segment deals with oil and gas exploration and production activities. The Transportation and Logistics segment comprises of pipelines and other transportation activities. The Refining and Petrochemicals segment involves in refining activities and its products include motor fuels, fuel oils, and petrochemicals. The company was founded in 1948 and is headquartered in Bogota, Colombia.

Ecopetrol SA - ADR

Ecopetrol SA

Ecopetrol is trending as investors weigh its potential as an undervalued energy play with a strong dividend yield against ongoing geopolitical risks in Colombia and shifting global oil market dynamics. The community is actively debating the stock's long-term outlook, focusing on the company's operational resilience and the impact of political developments on its future growth.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is experiencing significant community attention driven by its role as a backbone for stablecoin transfers and its expanding ecosystem, including integrations with major networks and partnerships. Traders are actively discussing its resilience during broader market volatility and its potential for growth as the leading infrastructure for global, low-cost crypto transactions.

OppFi, Inc. is a tech-enabled, mission-driven specialty finance platform, which engages in the provision of community banks to extend credit access to everyday Americans. It supports consumers, who are turned away by mainstream options, to build better financial health, through transparency, responsible lending, financial inclusion, and an excellent customer experience. The company was founded by Todd G. Schwartz and Theodore Schwartz in 2012 and is headquartered in Chicago, IL.

OppFi Inc - Ordinary Shares - Class A

OppFi Inc

OppFi Inc. is trending as investors weigh strong operational results, including record quarterly profitability and raised guidance, against concerns regarding the company's complex Up-C ownership structure. Community sentiment remains polarized, with many highlighting the stock's discounted valuation and aggressive share buybacks as a bullish setup, while others caution that the conversion of legacy ownership units continues to complicate GAAP earnings and long-term price performance.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is gaining institutional momentum ahead of its upcoming earnings as investors rotate out of technology and into resilient healthcare names, while the company leverages a robust portfolio of mature drugs and late-stage pipeline assets to navigate competitive pricing pressures. Market participants are closely watching the company's capital allocation strategy and manufacturing expansion efforts, which are being bolstered by favorable policy developments and a strengthening competitive position in the cardiovascular and inflammatory disease markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Negative Forecast for Harrow Earnings

Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities research analysts at HC Wainwright reduced their Q1 2026 earnings per share estimates for Harrow in a report issued on Wednesday, March 4th. HC...

HC Wainwright Has Pessimistic Outlook of Harrow Q3 Earnings

Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at HC Wainwright decreased their Q3 2026 earnings per share (EPS) estimates for shares of Harrow in a research note issued to investors...

Harrow (NASDAQ:HROW) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research lowered Harrow from a "hold" rating to a "strong sell" rating in a report on Tuesday...

Cantor Fitzgerald Lowers Harrow (NASDAQ:HROW) Price Target to $91.00

Cantor Fitzgerald lowered their price target on shares of Harrow from $94.00 to $91.00 and set an "overweight" rating for the company in a research report on Wednesday...

Harrow (NASDAQ:HROW) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright boosted their price objective on Harrow from $69.00 to $70.00 and gave the stock a "buy" rating in a research note on Wednesday...

Harrow Q4 Earnings Call Highlights

Harrow (NASDAQ:HROW) executives used the company's fourth-quarter 2025 earnings call to highlight what CEO Mark Baum described as a five-year transformation into a diversified ophthalmic platform...

Harrow (NASDAQ:HROW) Shares Gap Down After Earnings Miss

Harrow (NASDAQ:HROW) Shares Gap Down on Disappointing Earnings...

Harrow (HROW) Misses Q4 Earnings Estimates

Harrow (HROW) delivered earnings and revenue surprises of -34.46% and +0.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Harrow, Inc. $HROW Shares Sold by Royce & Associates LP

Royce & Associates LP cut its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 3.7% during the third quarter, according to its most recent Form 13F filing with the Securities and...

88,855 Shares in Harrow, Inc. $HROW Bought by Lumbard & Kellner LLC

Lumbard & Kellner LLC acquired a new position in Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities...

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.22	--	--	N/A
Q4 '25	$0.37	$0.17	-53.78%	MISSED
Q3 '25	$0.22	$0.03	-86.05%	MISSED
Q2 '25	$0.01	$0.13	1623.00%	BEAT
Q1 '25	-$0.05	-$0.50	-986.96%	MISSED

HROW
Harrow Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest HROW News

HROWHarrow Health Inc